• Exchange: OTC US
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

Cytomedix Inc

+ Add to Watchlist


0.3900 USD 0.0099 2.48%

As of 13:29:00 ET on 10/01/2014.

Snapshot for Cytomedix Inc (CMXI)

Open: 0.4000 Day's Range: 0.3851 - 0.4000 Volume: 35,380
Previous Close: 0.3999 52wk Range: 0.3300 - 0.6800 1-Yr Rtn: -1.27%

Stock Chart for CMXI

No chart data available.
  • CMXI:US 0.3900
  • 1D
  • 1M
  • 1Y
Interactive CMXI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CMXI

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.2510
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 48.40
Shares Outstanding (M) 124.41
30 Day Average Volume 458,178
Price/Book (mrq) 2.9670
Price/Sale (ttm) 3.8783
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CMXI

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CMXI

Cytomedix, Inc. is a global biotechnology company focused on developing and commercializing cellular therapies that serve unmet clinical needs. The Company markets the Autogel process and Procuren, autologous wound healing therapies with multiple growth factors designed to initiate the body's natural healing process.

David E JordenChairmanMartin P RosendaleChief Executive Officer
Dean Tozer Chief Commercial OfficerPeter ClausenChief Science Officer
More Company Profile & Key Executives for CMXI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil